Details for Patent: 6,479,535
✉ Email this page to a colleague
Which drugs does patent 6,479,535 protect, and when does it expire?
Patent 6,479,535 protects DUAVEE and is included in one NDA.
Summary for Patent: 6,479,535
Title: | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
Abstract: | The present invention relates to new formulations containing one or more estrogens and 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment utilizing these compounds, which have the general structures below: ##STR1## |
Inventor(s): | Pickar; James Harrison (Springfield, PA), Komm; Barry Samuel (Havertown, PA) |
Assignee: | Wyeth (Madison, NJ) |
Application Number: | 09/306,073 |
Patent Claim Types: see list of patent claims | Composition; Compound; Use; |
Drugs Protected by US Patent 6,479,535
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms | DUAVEE | bazedoxifene acetate; estrogens, conjugated | TABLET;ORAL | 022247-001 | Oct 3, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS | ⤷ Try a Trial | |||
Wyeth Pharms | DUAVEE | bazedoxifene acetate; estrogens, conjugated | TABLET;ORAL | 022247-001 | Oct 3, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |